Zydus Lifesciences gained 1.81% to Rs 1187.15 after the company announced that it has received a final approval from the United States Food and Drug Administration (USFDA) to market Sacubitril and Valsartan tablets.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
